08/03/22 4:15 PMNYSE : BIO, BIO.B acquisitionBio-Rad Acquires Curiosity DiagnosticsBio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A., a Warsaw, Poland, based developer of innovative technology solutions for the medical diagnostic and...RHEA-AIneutral
07/28/22 4:17 PMNYSE, OTC : BIO, BIO.B, SSSGY earningsBio-Rad Reports Second-Quarter 2022 Financial ResultsBio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2022. Second-quarter 2022 net sales were $691.1 million, a decrease of 3.5 percent compared to $715.9 million reported for the second quarter of 2021. Clinical Diagnostics segment net...RHEA-AIneutral
07/18/22 4:15 PMNYSE : BIO, BIO.B conferencesearningsBio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, will report its financial results for the second quarter of 2022 on Thursday, July 28, 2022, following the close of the market. To participate, call 844-200-6205 within the U.S. or +1 929-526-1599 outside the U.S., access code: 715914. About Bio-Rad Bio-Rad...RHEA-AIneutral
06/27/22 8:00 AMNYSE : BIO, BIO.B Bio-Rad Publishes Corporate Sustainability ReportBio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today released its inaugural corporate sustainability report. reducing Scope 1 and 2 carbon emissions by 46% purchasing renewable electricity for 100% of Bio-Rad’ s U.S. facilities increasing the proportion of women in the company’ s U.S. leadership roles...RHEA-AIvery positive
04/28/22 4:15 PMNYSE, OTC : BIO, BIO.B, SSSGY earningsBio-Rad Reports First-Quarter 2022 Financial ResultsBio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2022. First-quarter 2022 net sales were $700.1 million, a decrease of 3.7 percent compared to $726.8 million reported for the first quarter of 2021. Clinical Diagnostics segment net...RHEA-AIneutral
04/18/22 8:00 AMNYSE : BIO, BIO.B conferencesearningsBio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2022 on Thursday, April 28, 2022, following the close of the market. To listen, call 844-200-6205 within the U.S. or 929-526-1599 outside the U.S., access code: 493268. Bio-Rad Laboratories, Inc. is a global...RHEA-AIneutral
03/02/22 5:51 PMNYSE : BIO, BIO.B Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes OfferingBio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced today the closing of its underwritten public offering of $1.2 billion aggregate principal amount of the following notes, each issued at par:. Citigroup Global Markets Inc., Goldman Sachs& Co. LLC and J.P. Morgan Securities LLC acted as joint...RHEA-AIneutral
02/25/22 9:15 AMNYSE, OTC : BIO, BIO.B, SSSGY Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor DayBio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, is hosting an in-person investor day beginning at 10:30 a.m. EST today in New York City. During the event, members of Bio-Rad’ s executive leadership team will provide an in-depth overview of the Company’ s growth strategy and new long-term financial targets,...RHEA-AIvery positive
02/10/22 4:15 PMNYSE, OTC : BIO, BIO.B, SSSGY earningsBio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial ResultsBio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced financial results for the fourth quarter and year ended December 31, 2021. Fourth-quarter 2021 net sales were $732.8 million, a decrease of 7.2 percent compared to $789.8 million reported for the fourth quarter of 2020.RHEA-AIneutral
02/02/22 4:15 PMNYSE : BIO, BIO.B conferencesBio-Rad to Host Investor Day on February 25Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced today that it will host an in-person investor day in New York City on Friday, February 25, 2022, at 10:30 a.m. EST. The event will feature presentations from Norman Schwartz, Chief Executive Officer, and other key members of Bio-Rad’ s executive...RHEA-AIneutral
